A pharmacokinetic (PK) pharmacodynamic (PD) driven first-in-human study of the oral class I PI3K inhibitor CH5132799, in patients with advanced solid tumors

Aurelius Gabriel Omlin; James F. Spicer; Debashis Sarker; David James Pinato; Roshan Agarwal; Philippe Alexandre Cassier; Chara Stavraka; Monsterrat Blanco; Aneta Suder; Suzanne Allan; Simon Heaton; Shaun Decordova; Lorna Pope; Jenny Prince; Kohei Noguchi; Keith Jones; Michiyasu Inatani; Rie Shiokawa; Udai Banerji; Sarah Patricia Blagden

A pharmacokinetic (PK) pharmacodynamic (PD) driven first-in-human study of the oral class I PI3K inhibitor CH5132799, in patients with advanced solid tumors

Aurelius Gabriel Omlin, James F. Spicer, Debashis Sarker, David James Pinato, Roshan Agarwal, Philippe Alexandre Cassier, Chara Stavraka, Monsterrat Blanco, Aneta Suder, Suzanne Allan, Simon Heaton, Shaun Decordova, Lorna Pope, Jenny Prince, Kohei Noguchi, Keith Jones, Michiyasu Inatani, Rie Shiokawa, Udai Banerji, Sarah Patricia Blagden

Comprehensive Cancer Centre

Research output: Chapter in Book/Report/Conference proceeding › Meeting abstract › peer-review

Original language	English
Title of host publication	Journal of Clinical Oncology
Number of pages	1
Volume	30
Publication status	Published - 20 May 2012
Event	48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - Chicago, Israel Duration: 1 Jun 2012 → 6 Jun 2012

Conference

Conference	48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Country/Territory	Israel
Period	1/06/2012 → 6/06/2012

Cite this

Omlin, A. G., Spicer, J. F., Sarker, D., Pinato, D. J., Agarwal, R., Cassier, P. A., Stavraka, C., Blanco, M., Suder, A., Allan, S., Heaton, S., Decordova, S., Pope, L., Prince, J., Noguchi, K., Jones, K., Inatani, M., Shiokawa, R., Banerji, U., & Blagden, S. P. (2012). A pharmacokinetic (PK) pharmacodynamic (PD) driven first-in-human study of the oral class I PI3K inhibitor CH5132799, in patients with advanced solid tumors. In Journal of Clinical Oncology (Vol. 30)

@inbook{765a1ef4223a471a84b7bf5f095c66b8,

title = "A pharmacokinetic (PK) pharmacodynamic (PD) driven first-in-human study of the oral class I PI3K inhibitor CH5132799, in patients with advanced solid tumors",

author = "Omlin, {Aurelius Gabriel} and Spicer, {James F.} and Debashis Sarker and Pinato, {David James} and Roshan Agarwal and Cassier, {Philippe Alexandre} and Chara Stavraka and Monsterrat Blanco and Aneta Suder and Suzanne Allan and Simon Heaton and Shaun Decordova and Lorna Pope and Jenny Prince and Kohei Noguchi and Keith Jones and Michiyasu Inatani and Rie Shiokawa and Udai Banerji and Blagden, {Sarah Patricia}",

year = "2012",

month = may,

day = "20",

language = "English",

volume = "30",

booktitle = "Journal of Clinical Oncology",

note = "48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) ; Conference date: 01-06-2012 Through 06-06-2012",

}

Omlin, AG, Spicer, JF , Sarker, D, Pinato, DJ, Agarwal, R, Cassier, PA, Stavraka, C, Blanco, M, Suder, A, Allan, S, Heaton, S, Decordova, S, Pope, L, Prince, J, Noguchi, K, Jones, K, Inatani, M, Shiokawa, R, Banerji, U & Blagden, SP 2012, A pharmacokinetic (PK) pharmacodynamic (PD) driven first-in-human study of the oral class I PI3K inhibitor CH5132799, in patients with advanced solid tumors. in Journal of Clinical Oncology. vol. 30, 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Israel, 1/06/2012.

TY - CHAP

T1 - A pharmacokinetic (PK) pharmacodynamic (PD) driven first-in-human study of the oral class I PI3K inhibitor CH5132799, in patients with advanced solid tumors

AU - Omlin, Aurelius Gabriel

AU - Spicer, James F.

AU - Sarker, Debashis

AU - Pinato, David James

AU - Agarwal, Roshan

AU - Cassier, Philippe Alexandre

AU - Stavraka, Chara

AU - Blanco, Monsterrat

AU - Suder, Aneta

AU - Allan, Suzanne

AU - Heaton, Simon

AU - Decordova, Shaun

AU - Pope, Lorna

AU - Prince, Jenny

AU - Noguchi, Kohei

AU - Jones, Keith

AU - Inatani, Michiyasu

AU - Shiokawa, Rie

AU - Banerji, Udai

AU - Blagden, Sarah Patricia

PY - 2012/5/20

Y1 - 2012/5/20

M3 - Meeting abstract

VL - 30

BT - Journal of Clinical Oncology

T2 - 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Y2 - 1 June 2012 through 6 June 2012

ER -